Press release
Scleritis Market: Biologic Advances and Early Diagnosis Drive Growth to 2034
Scleritis Market
Growing autoimmune disease awareness, biologic drug adoption, and precision ophthalmology tools are driving steady growth in the global scleritis treatment market.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72281
Introduction
The Scleritis Market is witnessing gradual but significant growth as advances in biologic drugs, early autoimmune diagnostics, and ocular immunology research reshape disease management strategies.
Valued at USD 270 million in 2024, the market is projected to reach USD 490 million by 2034, expanding at a CAGR of 6.1% during the forecast period.
Scleritis, a rare but severe inflammatory eye disorder often linked to autoimmune conditions such as rheumatoid arthritis and granulomatosis with polyangiitis, poses vision-threatening risks. However, improved access to immunomodulatory treatments and diagnostic imaging technologies is enabling faster detection and more effective control.
Key Players in the Market
The market features leading pharmaceutical firms and emerging biotech companies focused on ocular inflammation and systemic autoimmune management.
Major players include:
• AbbVie Inc.
• Novartis AG
• Roche Holding AG
• Bausch Health Companies Inc.
• Regeneron Pharmaceuticals Inc.
• Allergan plc
• Sun Pharmaceutical Industries Ltd.
• Santen Pharmaceutical Co. Ltd.
• Hoffmann-La Roche AG
• Pfizer Inc.
These companies are developing TNF-alpha inhibitors, interleukin blockers, and biologic immunotherapies to target the underlying autoimmune pathways driving scleritis.
Key Events in the Last Five Years
• 2020-2021: Increased scleritis case reporting linked to autoimmune diseases spurred interest in multidisciplinary ophthalmology-rheumatology care models.
• 2022: AbbVie expanded indications for adalimumab (Humira) to include rare ocular inflammatory conditions.
• 2023: Roche and Novartis introduced biologics with dual immunomodulatory benefits, improving refractory case outcomes.
• 2024: AI-based retinal imaging tools gained traction for early inflammation detection and treatment monitoring.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72281/scleritis-market
Market Growth Rate
According to Exactitude Consultancy, the scleritis market will register a CAGR of 6.1% from 2025 to 2034, driven by:
• Increased autoimmune disease prevalence worldwide.
• Expanding adoption of biologic therapies in ophthalmology.
• Growing clinician awareness and faster referral networks.
• Technological innovations in ocular imaging and remote care.
This growth reflects a steady transition from corticosteroid-heavy regimens to precision-targeted, steroid-sparing biologic approaches.
Market Segments and Growth Analysis
The market is segmented by treatment type, disease type, and region.
By Treatment Type:
• Corticosteroids (Prednisone, Dexamethasone)
• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
• Immunosuppressive Agents (Methotrexate, Azathioprine, Mycophenolate Mofetil)
• Biologic Agents (Adalimumab, Infliximab, Rituximab)
• Surgical/Adjunctive Therapy
By Disease Type:
• Anterior Scleritis
• Posterior Scleritis
• Necrotizing and Diffuse Scleritis
By Region:
• North America: Dominates due to high biologic utilization and robust ophthalmology networks.
• Europe: Expanding patient access to monoclonal antibody therapies.
• Asia Pacific: Rapid growth driven by increased autoimmune disease detection in Japan, India, and South Korea.
• Latin America & MEA: Growing awareness and improved availability of generic immunosuppressants.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72281
Key Market Drivers
1. Biologic and Immunotherapy Advancements:
TNF inhibitors and B-cell targeted agents offer durable control for refractory scleritis cases.
2. Rising Autoimmune Disease Incidence:
Growing rheumatoid arthritis and vasculitis prevalence increases patient volume for secondary ocular complications.
3. Imaging and Diagnostic Innovation:
Optical coherence tomography (OCT) and ultrasound biomicroscopy aid in precise inflammation mapping.
4. Integration of AI in Ophthalmology:
Predictive algorithms help identify at-risk patients and prevent severe complications.
Recent Developments
• 2023: AbbVie's adalimumab showed positive long-term remission rates in scleritis associated with rheumatoid arthritis.
• 2024: Regeneron initiated trials using interleukin-6 blockade (Sarilumab) for severe refractory ocular inflammation.
• 2024: Santen Pharmaceutical expanded its inflammation product portfolio with new topical immunomodulators.
• 2024: Novartis launched an AI-powered platform for clinical image interpretation to improve differential diagnosis accuracy.
Expert Insight
"Scleritis remains a complex disease, but our expanding biologic toolbox and digital imaging capabilities are redefining its management. We are finally shifting from reactive care to proactive, personalized treatment,"
- Dr. Elena Vasquez, Ophthalmic Immunologist, University of Barcelona.
Conclusion
The Scleritis Market is evolving toward more targeted, patient-centric treatment approaches.
With growing biologic adoption, multidisciplinary care models, and AI-based diagnostics, the field is moving beyond symptom control to sustained remission and improved visual prognosis.
As clinical collaborations between ophthalmologists and rheumatologists deepen, the global market will continue to see strong innovation through 2034.
This report is also available in the following languages : Japanese (強膜炎市場), Korean (강막염 시장), Chinese (巩膜炎市场), French (Marché de la sclérite), German (Skleritis-Markt), and Italian (Mercato della sclerite), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72281
Our More Reports:
Vaccine Delivery Devices Market
https://exactitudeconsultancy.com/reports/73477/vaccine-delivery-devices-market
Amyloidosis Clinical Market
https://exactitudeconsultancy.com/reports/73634/amyloidosis-clinical-market
Women's Digital Health Fundamental Analysis Market
https://exactitudeconsultancy.com/reports/73703/women-s-digital-health-fundamental-analysis-market
Clinical Trial Software Market
https://exactitudeconsultancy.com/reports/73711/clinical-trial-software-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Scleritis Market: Biologic Advances and Early Diagnosis Drive Growth to 2034 here
News-ID: 4259013 • Views: …
More Releases from Exactitude Consultancy
Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitatio …
The global cold planer market is experiencing steady growth as governments and private contractors increase spending on road rehabilitation, resurfacing, and infrastructure modernization. Cold planers, also known as milling machines, are widely used to remove damaged asphalt and concrete surfaces efficiently, supporting sustainable road construction practices.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68250
Key Market Highlights
• Increasing focus on road maintenance and resurfacing projects
• Growing demand for efficient and precision milling…
Credit Management Software Market Accelerates as Organizations Focus on Risk Mit …
The global credit management software market is witnessing robust growth as organizations across industries adopt digital solutions to manage credit risk, improve receivables performance, and strengthen financial controls. Credit management software enables businesses to automate credit scoring, monitor customer creditworthiness, and streamline collections processes.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68248
Key Market Highlights
• Growing adoption of automated credit risk assessment tools
• Increasing focus on working capital and cash flow management
• Integration…
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Oper …
The global session border controller (SBC) market is experiencing strong growth as telecom operators and enterprises increasingly deploy SBC solutions to secure, manage, and optimize real-time IP communications. SBCs play a critical role in protecting voice over IP (VoIP), unified communications (UC), and multimedia sessions from cyber threats while ensuring interoperability and quality of service.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68246
Key Market Highlights
• Growing adoption of VoIP and…
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Tr …
The global biofuel market, encompassing e-methane, sustainable aviation fuel (SAF), and other advanced biofuels, is witnessing robust growth as governments and industries intensify efforts to reduce carbon emissions and transition toward cleaner energy sources. These fuels play a critical role in achieving net-zero targets while enabling decarbonization of hard-to-abate sectors such as aviation, shipping, and heavy transportation.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68244
Key Market Highlights
• Rapid growth of…
More Releases for Scleritis
Global Scleritis Market Expected to Achieve 8.7% CAGR by 2029: Growth Forecast I …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Scleritis Market Size By 2025?
The overall valuation of the scleritis market has seen robust expansion lately, projected to climb from its 2024 standing of $3.6 billion to reach $3.93 billion by 2025, reflecting a 9.0% compound annual growth rate during this interval. This…
Scleritis Market to Reach USD 2.2 Billion by 2034
Scleritis is a serious inflammatory disease of the sclera, the white outer coating of the eye. It is often associated with systemic autoimmune conditions such as rheumatoid arthritis, granulomatosis with polyangiitis, lupus, and inflammatory bowel disease. Symptoms include severe ocular pain, redness, and potential vision loss if untreated.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72281
Unlike episcleritis, scleritis is more severe and frequently requires systemic immunosuppressive therapy or biologics.…
Strong Growth Ahead: Scleritis Market Size To Grow At Arecord 8.9% Cagr By 2029
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
How Big Is the Scleritis Market Size Expected to Be by 2034?
The market for scleritis has seen significant growth in the past few years. The market, which was worth $3.60 billion in 2024, is expected to reach a value of $3.94 billion in 2025, growing at a compound annual growth rate…
Scleritis Market Set to Reach $5.54 Billion by 2029 with 8.9% Yearly Growth
How Are the key drivers contributing to the expansion of the scleritis market?
The increasing prevalence of autoimmune diseases is expected to drive the growth of the scleritis market. Autoimmune diseases are conditions where the body's immune system mistakenly attacks healthy cells and tissues, thinking they are foreign invaders. The rise in autoimmune diseases is linked to genetic predispositions, environmental factors, lifestyle changes, and increased awareness, leading to better diagnosis. Autoimmune…
Scleritis Market Business Opportunities And Regional Outlook 2022-28
According to Precision Business Insights (PBI), latest report, the scleritis market is expected to have a CAGR of 5.8% during the forecast period 2022 to 2028. The primary drivers of the expansion of the global scleritis market include the increasing prevalence of scleritis, the growing geriatric population, developing healthcare infrastructure in economic countries, and technological advancements in treatment and diagnosis.
View the detailed report description here - https://precisionbusinessinsights.com/market-reports/scleritis-market/ …
Healthcare Scleritis Market : Technological Breakthroughs, Value Chain And Stake …
Scleritis Market Information, by Types (Diffuse Anterior Scleritis, Nodular Anterior Scleritis, Necrotizing Anterior Scleritis, Necrotizing Anterior Scleritis, Posterior Scleritis) by treatment types (Non-Steroidal Anti-Inflammatory Drugs, Oral Glucocorticoids, Immunosuppressive Drugs) - Forecast to 2022
Study objectives of the Market:
• To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the Scleritis market
• To provide insights about factors affecting the market growth
• To…
